A new study reveals that methylprednisolone and budesonide inhalation suspension showed limited differences in young patients with bronchial asthma attacks.
Methylprednisolone and budesonide inhalation suspension showed limited differences regarding the severity of attacks, duration of management, duration of wheezing and hospitalization in patients with moderate bronchial asthma attacks, according to study results.
Researchers in Japan randomly assigned 40 patients, aged 5 years or younger, hospitalized for moderate bronchial asthma attacks between October 2008 and March 2010 to methylprednisolone (mPSL; n = 20) or budesonide inhalation suspension (BIS; n =20).
The researchers’ sought to determine whether BIS could replace intravenous steroid administration as therapy for bronchial asthma attacks.
